Clinical Trial Update: GOS and Insulin Sensitivity [NA]

View source ↗

Summary

Clinical trial update reporting a completed study on galacto-oligosaccharides (GOS) and insulin sensitivity in individuals with obesity and type 2 diabetes mell…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Type 2 Diabetes Mellitus

Drugs mentioned

• Galacto-oligosaccharides (GOS) (galacto-oligosaccharides)

Snippet

Sponsor: Maastricht University Medical Center | Conditions: Obesity, Type 2 Diabetes Mellitus | NA | Status: COMPLETED